Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR- mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial
Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR- mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial.